Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 567,045 | 351,985 | 176,268 | 175,644 | 24,864 |
| Marketable Securities | 311,869 | N/A | N/A | N/A | N/A |
| Other current assets | 26,878 | 1,308 | 1,838 | 1,312 | 1,373 |
| TOTAL | $917,192 | $373,095 | $202,439 | $182,015 | $27,369 |
| Non-Current Assets | |||||
| PPE Net | 6,803 | 1,655 | 978 | N/A | N/A |
| Other Non-Current Assets | 36,574 | 14,495 | 116 | 116 | 65 |
| TOTAL | $43,377 | $16,150 | $1,094 | $116 | $65 |
| Total Assets | $960,569 | $389,245 | $203,534 | $182,132 | $27,433 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,667 | 0 | N/A |
| Accounts payable and accrued liabilities | 8,477 | 8,361 | 10,255 | 3,663 | 2,547 |
| Accrued Expenses | 111,935 | 54,783 | 5,103 | 2,891 | 1,092 |
| Other current liabilities | 4,230 | N/A | N/A | N/A | N/A |
| TOTAL | $128,327 | $65,753 | $17,025 | $6,554 | $3,639 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 142,567 | 25,378 | 26,390 | N/A |
| Other Non-Current Liabilities | 627,685 | 146,696 | 159 | 244 | 0 |
| TOTAL | $627,685 | $289,263 | $25,536 | $26,635 | $N/A |
| Total Liabilities | $756,012 | $355,016 | $42,561 | $33,189 | $3,639 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,375 | 75,321 | 56,279 | 50,373 | N/A |
| Common Shares | 8 | 6 | 6 | 5 | 1 |
| Retained earnings | -926,347 | -581,473 | -276,766 | -149,264 | -98,258 |
| Other shareholders' equity | -117 | -154 | -123 | 0 | 92,055 |
| TOTAL | $204,557 | $34,229 | $160,973 | $148,943 | $23,794 |
| Total Liabilities And Equity | $960,569 | $389,245 | $203,534 | $182,132 | $27,433 |